Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05471232 · ClinicalTrials.gov registry record

Mental Health Crises in Youth With IDDs

A clinical trial of Intellectual Disability, sponsored by Rady Pediatric Genomics & Systems Medicine Institute.

Recruiting
Registry status
150
Enrollment target
1
Study location

NCT05471232: Recruiting study of Intellectual Disability, sponsored by Rady Pediatric Genomics & Systems Medicine Institute.

NCT05471232 is a study of Intellectual Disability that is actively recruiting participants, run by Rady Pediatric Genomics & Systems Medicine Institute. The registered enrollment target is 150 participants, below the 348-participant average among 26 other Intellectual Disability trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05471232, a study of Intellectual Disability, is actively recruiting participants, sponsored by Rady Pediatric Genomics & Systems Medicine Institute.

RECRUITING
Registry status
150 participants
Enrollment target
1
Study location

Study Summary

This study is an unmatched, case-control study of 150 youth (Ages 7-17) with a parent reported Intellectual Developmental Disability (IDD) who present to Rady Children's Hospital Emergency Department with a Mental Health Crisis (MHC). Rady Children's Institute for Genomic Medicine (RCIGM) will collect biological samples (such as blood) of these participants to study their genomes, medical and psychiatric profiles to better understand specific characteristics that may predispose them to MHC's. The 150 youth will be compared to historical, publicly available cohorts of youth with IDD's

Primary Outcome

Area under the receiver operating characteristic curve for a network model that predicts psychiatric outcomes for youth with intellectual and developmental disabilities. Area under the receiver operating characteristic curve has a minimum value of 0.5 and a maximum value of 1, where higher scores represent more accurate predictions of psychiatric outcomes.

Conditions Studied

Interventions

  • GENETIC Genomic sequencing and molecular diagnostic results, if any.
  • OTHER EHR-Based Network Model

Study Locations (1)

California

  • Rady Children's Hospital San Diego - San Diego

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2023-03-29
Est. Completion 2027-07-01

What NCT05471232 shows while recruiting

NCT05471232 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 348-participant average among 26 other Intellectual Disability trials with a reported enrollment target (57% lower).

The record links to 1 condition, with Intellectual Disability appearing as the primary indexed condition, and to 2 interventions - of which Genomic sequencing and molecular diagnostic results, if any. is the first listed.

NCT05471232 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05471232 about?

NCT05471232 is a clinical study titled "Mental Health Crises in Youth With IDDs". This study is an unmatched, case-control study of 150 youth (Ages 7-17) with a parent reported Intellectual Developmental Disability (IDD) who present to Rady Children's Hospital Emergency Department with a Mental Health Crisis (MHC). Rady Children's Institute for Genomic Medicine (RCIGM) will colle...

What is the current status of trial NCT05471232?

This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2023-03-29. Estimated completion is 2027-07-01.

What conditions does trial NCT05471232 study?

This clinical trial studies the following conditions: Intellectual Disability.

What interventions are being tested in trial NCT05471232?

The interventions under investigation include: Genomic sequencing and molecular diagnostic results, if any. (GENETIC), EHR-Based Network Model (OTHER).

Who is sponsoring clinical trial NCT05471232?

This trial is sponsored by Rady Pediatric Genomics & Systems Medicine Institute, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05471232 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intellectual Disability

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05471232's enrollment target sits among peer trials

150 13th of 26 higher than 13 of 26 other Intellectual Disability trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Intellectual Disability trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05471232, the US trial registry maintained by the National Library of Medicine. NCT05471232 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.